# reload+after+2024-01-20 08:47:30.758452
address1§Maxim 1
address2§2 Parklands Way Holytown
city§Motherwell
zip§ML1 4WR
country§United Kingdom
phone§44 14 1433 7557
website§https://tcbiopharm.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
fullTimeEmployees§60
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Bryan L. Kobel', 'age': 42, 'title': 'CEO & Director', 'yearBorn': 1981, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Martin E. Thorp', 'age': 71, 'title': 'CFO & Director', 'yearBorn': 1952, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Christopher  Camarra', 'title': 'Executive Vice President of Communications', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Lauren  Bor Ph.D.', 'title': 'Head of Commercial Development Division', 'exercisedValue': 0, 'unexercisedValue': 0}]
maxAge§86400
priceHint§4
payoutRatio§0.0
priceToSalesTrailing12Months§0.5260006
currency§USD
dateShortInterest§1702598400
forwardEps§-4.6
exchange§NCM
quoteType§EQUITY
shortName§TC BioPharm (Holdings) plc
longName§TC Biopharm (Holdings) Plc
firstTradeDateEpochUtc§1644589800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§ef544858-646b-3e8d-bcb0-2aed3539a593
gmtOffSetMilliseconds§-18000000
targetHighPrice§140.0
targetLowPrice§140.0
targetMeanPrice§140.0
targetMedianPrice§140.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§0.952
earningsGrowth§-0.868
grossMargins§1.0
ebitdaMargins§0.0
trailingPegRatio§None
